SCHEMBL2587022

SCHEMBL2587022

COCC1(OC)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12389945 0.88
SCHEMBL17850691 0.87 ACACB (0.30)
SCHEMBL15277097 0.86
SCHEMBL15076435 0.82 PIM1 (0.33)
SCHEMBL12199296 0.82
SCHEMBL14677605 0.82
SCHEMBL15806855 0.80 SLC6A2 (0.32)
SCHEMBL14676314 0.78 ACACB (0.32)
SCHEMBL16080652 0.77 NSD2 (0.38)
SCHEMBL16080653 0.77 NSD2 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2429568-B1 MACROCYCLIC COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS ENANTA PHARM INC (US) 2016-08-17 EP disclosed
CN-105073745-A Glucosylceramide synthase inhibitors GENZYME CORP 2015-11-18 CN disclosed
US-8047638-B2 Liquid ejecting apparatus KONICA MINOLTA HOLDINGS, INC. (JP) 2011-11-01 US disclosed
WO-2010132163-A1 MACROCYCLIC COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2010-11-18 WO disclosed
US-20090079794-A1 LIQUID EJECTING APPARATUS KONICA MINOLTA HOLDINGS, INC. (JP) 2009-03-26 US disclosed
CN-101151247-A 3,4, 5-substituted piperidines as renin inhibitors SPEEDEL EXPERIMENTA AG (CH) 2008-03-26 CN disclosed